APA (7th ed.) Citation

M, G., JE, M., L, D., M, S., EM, E., C, R., . . . J, Z. (2026). Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions. Journal of cellular and molecular medicine, 30(13), e71280. https://doi.org/10.1111/jcmm.71280

Chicago Style (17th ed.) Citation

M, García-Colomer, et al. "Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions." Journal of Cellular and Molecular Medicine 30, no. 13 (2026): e71280. https://doi.org/10.1111/jcmm.71280.

MLA (9th ed.) Citation

M, García-Colomer, et al. "Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions." Journal of Cellular and Molecular Medicine, vol. 30, no. 13, 2026, p. e71280, https://doi.org/10.1111/jcmm.71280.